COVID-19 Treatment Study for High-Risk Adults
A Phase 3 study evaluating an investigational oral antiviral for adults who have recently tested positive for COVID-19 and are at higher risk for severe illness. Contact us immediately after a positive test. Compensation up to $1,100.
CHICKENPOX (Varicella) Vaccine Study
A clinical research study evaluating a chickenpox vaccine in healthy toddlers ages 12–15 months. Study-related visits at no cost. Compensation up to $600 for qualifying families.
AZURE Study
A Phase 3 study investigating whether an investigational medication can reduce the risk of heart attack or stroke in adults with cardiovascular disease or at high risk. Compensation up to $1,600.
SUNFLOWER Study
A Phase 3 study for women with non-atypical endometrial hyperplasia comparing Mirena to oral hormone therapy. Compensation up to $1,600.
ROCHE Weight Loss Study
A Phase 3 study evaluating an investigational medication for chronic weight management in adults with obesity or overweight without Type 2 Diabetes. Compensation up to $3,500.